The emergence of mephedrone and other synthetic cathinones has introduced worries for lawmakers and regulatory companies tasked with controlling the proliferation of recent psychoactive substances. The dynamic nature of synthetic drug production, coupled with the power of chemists to modify molecular buildings to evade lawful restrictions, complica… Read More